Corporate Profile

LabCorp (NYSE: LH), an S&P 500 company, is a leading global life sciences company that is deeply integrated in guiding patient care, providing comprehensive clinical laboratory and end-to-end drug development services. With a mission to improve health and improve lives, LabCorp delivers world-class diagnostic solutions, brings innovative medicines to patients faster and uses technology to improve the delivery of care. LabCorp reported net revenues of over $10 billion in ... Read More >>

Upcoming Events

There are currently no events scheduled.

Recent News

08/16/18

The National Football League Alumni, Cancer Treatment Centers of America®, LabCorp® and Health Testing Centers Team Up to Offer Prostate Cancer Screenings in September

07/25/18

LabCorp Announces 2018 Second Quarter Results and Updates 2018 Guidance

07/12/18

Robert E. Mittelstaedt, Jr. to Retire from LabCorp Board of Directors and Current Board Member Adam H. Schechter to Assume Role of Lead Independent Director in 2019

LH (Common)
ExchangeNYSE
Price$178.76
Change Stock is Down 0.45
Data as of 08/16/18 3:55 p.m. ET
Refresh quote
Data provided by Nasdaq. Minimum 15 minutes delayed.
Print Page Print Page | E-mail Page E-mail Page | RSS Feeds RSS Feeds | E-mail Alerts E-mail Alerts | IR Contacts IR Contacts | Financial Tear Sheet Tear Sheet